Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sector: Key Risk Considerations

April 7, 2025

AnJie Broad Partners at ABA Asia-Pacific Forum in Singapore

March 17, 2025

Highlights of China’s First Horizontal Merger Review Guidelines

January 20, 2025

SAMR Merger Control Statistics in the First Half of 2024

August 13, 2024

First Publicly Released Sanction for Gun-jumping under China’s Amended Anti-monopoly Law: Fines of RMB 1.5 Million Imposed on Each of the Undertakings

June 18, 2024

Legal Basis for Policy Conversion in China

May 13, 2024

Antitrust Compliance Incentive Mechanism in China

April 19, 2024

The Value and Significance of the Rare Earth Antitrust Litigation

February 27, 2024

The Boundary of AML’s Application in the Intellectual Property Realm

February 27, 2024

Does the Ongoing SAMR Merger Review Stop Enforcement of the Arbitral Awards?

August 15, 2023